SS INNOVATIONS INTERNATIONAL, INC. (SSII) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $1.00; Common Stock, Value, IssuedUSD $20.02K; Additional Paid in CapitalUSD $118.51M; Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after TaxUSD $20.87K.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $1.00; Common Stock, Value, IssuedUSD $20.01K; Additional Paid in CapitalUSD $116.55M; Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after TaxUSD $-4.78K.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $1.00; Common Stock, Value, IssuedUSD $19.42K; Additional Paid in CapitalUSD $95.11M; Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after TaxUSD $15.84K.
- 2025-09-30: Preferred Stock, Value, IssuedUSD $1.00; Common Stock, Value, IssuedUSD $19.36K; Additional Paid in CapitalUSD $93.35M; Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after TaxUSD (m).
SS INNOVATIONS INTERNATIONAL, INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Other USD | Additional Paid in Capital, Common Stock USD | Treasury Stock, Value USD | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD | Treasury Stock, Common, Shares shares | Treasury Stock, Value, Acquired, Cost Method USD | Adjustments to Additional Paid in Capital, Warrant Issued USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.00 | $20.02K | $118.51M | $20.87K | $-3.99M | $-62.03M | $53.40M | (m) | 3 month · $1.79M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $1.00 | $20.01K | $116.55M | $-4.78K | $-3.57M | $-59.37M | $54.52M | (m) | 3 month · $1.93M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $1.00 | $19.42K | $95.11M | $15.84K | $-2.02M | $-55.79M | $38.22M | (m) | 12 month · $2.70M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $1.00 | $19.36K | $93.35M | (m) | $-1.30M | $-53.32M | $39.65M | (m) | 3 month · $1.78M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $1.00 | $19.36K | $91.53M | $19.82K | $-822.81K | $-49.60M | $42.02M | (m) | 3 month · $1.58M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $1.00 | $19.35K | $89.71M | (m) | $-726.91K | $-49.34M | $40.55M | (m) | 3 month · $2.11M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $1.00 | $17.16K | $56.95M | $14.23K | $-749.62K | $-43.66M | $13.46M | (m) | 12 month · $7.80M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $1.00 | $17.09K | $54.85M | (m) | $-340.17K | $-41.74M | $13.69M | (m) | 3 month · $2.18M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $1.00 | $17.07K | $52.63M | (m) | $-279.14K | $-38.49M | $14.77M | 3 month · $2.18M | 3 month · $2.18M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $1.00 | $17.07K | $50.45M | (m) | $-266.31K | $-34.35M | $16.75M | 3 month · $6.84M | 3 month · $6.84M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $1.00 | $17.07K | $43.46M | (m) | $-195.50K | $-24.51M | $19.72M | (m) | 12 month · $3.74M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $1.00 | $16.92K | $27.96M | (m) | $-143.68K | $-12.37M | $16.37M | (m) | 3 month · $24.45K | (m) | $36.19M | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $1.00 | $14.62K | $10.68M | (m) | $-9.37K | $-10.47M | $1.12M | 3 month · $8.15K | 3 month · $8.15K | 3 month · $85.62K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | $6.54K | $13.04M | (m) | (m) | $-12.70M | $-4.04M | 3 month · $1.60M | 3 month · $1.60M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | $12.82K | $-12.81K | (m) | $54.60K | $-3.63M | $-2.68M | 12 month · $679.61K | (m) | (m) | $11.01M | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | (m) | $4.08K | $9.39M | (m) | (m) | $-9.52M | $-1.66M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $26.00K | (m) |
| 2022-06-30 | (m) | $3.81K | $8.31M | (m) | (m) | $-8.73M | $-1.15M | (m) | 3 month · $25.19K | (m) | (m) | $26.00K | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | $3.79K | $8.21M | (m) | (m) | $-8.56M | $-377.05K | (m) | 3 month · $27.48K | (m) | (m) | $26.00K | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | $3.79K | $8.18M | (m) | (m) | $-8.48M | $585.61K | (m) | (m) | (m) | (m) | $26.00K | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | $2.85K | (m) | (m) | (m) | $-8.12M | $-941.50K | (m) | (m) | (m) | $6.74M | (m) | (m) | (m) | (m) | (m) |
| 2021-07-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 629.38K | (m) | (m) |
| 2021-06-30 | (m) | $2.71K | (m) | (m) | (m) | $-7.71M | $-857.93K | (m) | (m) | (m) | $6.60M | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | $2.67K | (m) | (m) | (m) | $-7.29M | $-759.50K | (m) | (m) | (m) | $6.38M | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | $2.57K | $6.02M | (m) | (m) | $-6.99M | $-869.05K | (m) | (m) | (m) | $6.02M | (m) | $-869.05K | (m) | (m) | (m) |
| 2020-09-30 | (m) | $2.30K | (m) | (m) | (m) | $-6.77M | $-1.32M | (m) | (m) | (m) | $5.25M | (m) | $-1.32M | (m) | (m) | (m) |
| 2020-06-30 | (m) | $2.30K | (m) | (m) | (m) | $-6.40M | $-1.21M | (m) | (m) | (m) | $5.03M | (m) | $-1.21M | (m) | (m) | (m) |
| 2020-03-31 | (m) | $2.30K | (m) | (m) | (m) | $-6.18M | $-1.09M | (m) | (m) | (m) | $5.00M | (m) | $-1.09M | (m) | (m) | (m) |
| 2019-12-31 | (m) | $2.19K | (m) | (m) | (m) | $-5.87M | $-1.06M | (m) | (m) | (m) | $4.55M | (m) | $-1.06M | (m) | (m) | (m) |
| 2019-09-30 | (m) | $2.21K | (m) | (m) | (m) | $-4.26M | $-1.77M | (m) | (m) | (m) | $3.37M | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | $2.14K | (m) | (m) | (m) | $-3.18M | $-673.87K | (m) | (m) | (m) | $2.50M | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | (m) | $2.11K | (m) | (m) | (m) | $-2.79M | $-386.91K | (m) | (m) | (m) | $2.33M | (m) | (m) | (m) | (m) | 3 month · $16.22K |
| 2018-12-31 | (m) | $2.10K | (m) | (m) | (m) | $-2.48M | $-223.04K | (m) | (m) | (m) | $2.18M | (m) | (m) | (m) | (m) | (m) |
| 2018-09-30 | (m) | $2.09K | (m) | (m) | (m) | $-2.26M | $-264.21K | (m) | (m) | (m) | $1.98M | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | $2.09K | (m) | (m) | (m) | $-1.97M | $-33.54K | (m) | (m) | (m) | $1.93M | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | $2.09K | (m) | (m) | (m) | $-1.76M | $164.92K | (m) | (m) | (m) | $1.92M | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | $2.06K | (m) | (m) | (m) | $-1.52M | $101.09K | (m) | (m) | (m) | $1.62M | (m) | (m) | (m) | (m) | (m) |
| 2017-09-30 | (m) | $2.06K | (m) | (m) | (m) | $-1.11M | $380.51K | (m) | (m) | (m) | $1.56M | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | $1.92K | (m) | (m) | (m) | $-868.74K | $-453.15K | (m) | (m) | (m) | $413.67K | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | (m) | $1.90K | (m) | (m) | (m) | $-485.05K | $-355.06K | (m) | (m) | (m) | $128.09K | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | $-66.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| CARLSMED, INC. (CARL) | United States | $0.405B |